XML 64 R47.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity Incentive Plans (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Activity
The table below summarizes the restricted stock activity for the year ended December 31, 2024.
Number of SharesWeighted
Average
Grant Date
Fair Value
(in dollars)
2012 Omnibus Incentive Plan
Stock Ownership Participation Program
Total
Nonvested restricted stock at December 31, 2023926 17 943 $63.00 
Granted355 21 376 $98.94 
Vested(388)(17)(405)$61.32 
Forfeited(76)(2)(78)$77.14 
Nonvested restricted stock at December 31, 2024817 19 836 $78.68 
Schedule of Performance-Based Stock Activity
The table below summarizes the performance-based stock activity for the year ended December 31, 2024. All nonvested performance-based stock outstanding at December 31, 2024 and 2023 was granted under the 2012 Omnibus Incentive Plan.
Number of
Shares		Weighted
Average
Grant Date
Fair Value
(in dollars)
Nonvested performance-based stock at December 31, 2023454 $60.72 
Granted(1)
265 $99.40 
Vested(264)$53.29 
Forfeited(2)
(34)$78.93 
Nonvested performance-based stock at December 31, 2024(3)
421 $78.27 
(1)Shares granted in 2024 are presented at the stated target, which represents the base number of shares that could be earned. Actual shares earned may be below or, for certain grants, above the target based on the achievement of specific financial goals.
(2)Forfeited shares include shares forfeited as a result of not meeting the performance criteria of the award as well as shares forfeited upon termination.
(3)Of the 421,000 nonvested performance-based shares outstanding as of December 31, 2024, 327,236 shares were unearned and subject to achievement of specific financial goals. Once earned, the awards will be subject to time-based vesting according to the terms of the award. Based on 2024 financial results, approximately 67,451 of the 327,236 unearned shares will be forfeited in the first quarter of 2025.
Schedule of Share-based Payment Arrangement, Performance-Based Option, Valuation Assumptions [Table Text Block]
The fair values of the performance-based stock options granted during 2024 and 2023 were calculated using the Black-Scholes option pricing model using the following assumptions:
202420232022
Black-Scholes performance-based option pricing model:
Expected dividend yield—%—%—%
Expected volatility40.0%40.0%40.0%
Risk-free rate
4.2%
4.4%
1.6% / 2.6%
Expected option life (in years)4.5 years4.5 years
4.5 years
Share-based Payment Arrangement, Performance-Based Option, Activity
Performance-based stock option activity for the year ended December 31, 2024 was as follows:
Number
of
Performance-based Options
(in thousands)		Weighted
Average
Exercise
Price
(in dollars)		Weighted
Average
Remaining
Contractual
Term
(in years)		Aggregate
Intrinsic
Value
(in millions)
Outstanding at December 31, 2023181 $63.73 5.5$7.1 
Granted(2)
42 $99.40 
Exercised(33)$55.55 $1.6 
Forfeited or expired(26)$76.90 
Outstanding at December 31, 2024(1)(3)
164 $72.44 5.0$8.5 
Exercisable at December 31, 202448 $59.82 4.5$3.1 
(1)All of the outstanding performance-based stock options were granted under the 2012 Omnibus Incentive Plan.
(2)Performance-based stock options granted in 2024 are presented at the stated target, which represents the base number of options that could be earned. Actual options earned may be below or, for certain grants, above the target based on the achievement of specific financial goals.
(3)Of the 164,000 outstanding performance-based stock options as of December 31, 2024, 39,327 were unearned and subject to achievement of specific financial goals. Once earned, the options will be subject to time-based vesting according to the terms of the award. Based on 2024 financial results, approximately 28,138 of the 39,327 unearned options will be forfeited in the first quarter of 2025.
Schedule of Stock Option Activity
Time-vested stock option activity for the year ended December 31, 2024 was as follows:
Number
of
Time-vested Options
(in thousands)		Weighted
Average
Exercise
Price
(in dollars)		Weighted
Average
Remaining
Contractual
Term
(in years)		Aggregate
Intrinsic
Value
(in millions)
Outstanding at December 31, 202325 $52.49 4.7$1.3 
Granted— 
Exercised— 
Forfeited or expired— 
Outstanding at December 31, 2024(1)
25 $52.49 3.8$1.8 
Exercisable at December 31, 202413 $52.49 3.8$0.9 
(1)All of the outstanding time-vested stock options were granted under the 2012 Omnibus Incentive Plan.